首页|乳核散结片抗炎镇痛的药理实验研究

乳核散结片抗炎镇痛的药理实验研究

Pharmacological Study of Ruhe Sanjie Tablet for Anti-inflammation and Analgesia

扫码查看
目的:探讨乳核散结片的抗炎及镇痛作用.方法:用SD大鼠棉球肉芽肿实验和二甲苯致小鼠毛细血管通透性增加实验,观察乳核散结片的抗炎作用;同时建立冰醋酸致小鼠扭体实验,观察乳核散结片的止痛作用.结果:乳核散结片低、中、高剂量组均能显著抑制大鼠肉芽增生,与空白对照组比较,差异均有统计学意义(均P<0.05),其抑制率分别为30.0%、47.4%、53.6%,且呈量效关系.乳核散结片低、中、高剂量组均能有效降低小鼠毛细血管通透性,蓝斑光密度(OD)值与同期空白对照组比较,差异均有统计学意义(均P<0.001),其对毛细血管通透性抑制率分别为47.6%、55.0%、65.2%,并呈量效关系.乳核散结片低、中、高剂量组均能有效减少冰醋酸致小鼠扭体次数(P<0.001),其镇痛抑制率分别为34.2%、42.0%、51.5%,呈量效关系.结论:乳核散结片药理实验研究表明其具有抗炎及镇痛作用.
Objective:To investigate the anti-inflammatory and analgesic effects of Ruhe Sanjie Tablet.Methods:Cotton pellet-in-duced granuloma formation of Sprague Dawley(SD)rats and the increase in capillary permeability of mice induced by xylene were used to observe the anti-inflammatory effect of Ruhe Sanjie Tablet.The acetic acid writhing experiment in mice was established to observe the analgesic effect of the prescription.Results:The low-,medium-and high-dose Ruhe Sanjie Tablet inhibited the prolifera-tion of rat granulation tissue,and there were differences compared with the blank control group(all P<0.05).The inhibition rates of the three doses were 30.0%,47.4%and 53.6%,respectively,showing a dose-effect relationship.Ruhe Sanjie Tablet at low,medium and high doses reduced the capillary permeability of mice,and the optical density(OD)was lower than that in the blank control group(all P<0.001).The inhibition rates of capillary permeability were 47.6%,55.0%and 65.2%,respectively,with a dose-effect relationship.Ruhe Sanjie Tablet at each dose lowered the number of writhing induced by acetic acid in mice(P<0.001),and the analgesic inhibition rates at low,medium and high dose were 34.2%,42.0%and 51.5%,respectively,presenting a dose-effect relationship.Conclusion:Pharmacological studies of Ruhe Sanjie Tablet indicates that it has anti-inflammatory and analgesic effects.

Ruhe Sanjie TabletAnti-inflammationAnalgesiaCurative effectPharmacological studyCapillary permeabilityConnective tissue hyperplasiaRupixiao

黄秋凌、郑明翠、宁娜

展开 >

广州白云山中一药业有限公司,广州,510530

广州白云山奇星药业有限公司,广州,510530

乳核散结片 抗炎 镇痛 疗效 药理实验 毛细血管通透性 结缔组织增生 乳癖消

广东省重点领域研发计划

2020B1111110004

2023

世界中医药
世界中医药学会联合会

世界中医药

CSTPCDCHSSCD北大核心
影响因子:1.266
ISSN:1673-7202
年,卷(期):2023.18(22)
  • 18